| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 6.1 | 2.0 | 5.8 |
| Other income | 0.1 | 0.2 | 0.1 |
| Total income | 6.2 | 2.2 | 5.9 |
| Profit before exceptional items & tax | 0.2 | -0.4 | 0.2 |
| Profit before tax | 0.2 | -0.4 | 0.2 |
| Net profit | 0.2 | 0.6 | 0.2 |
| Operating margin | 3.2% | -18.2% | 3.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | -66.70% |
| Revenue, year on year | +5.20% |
| Operating profit, quarter on quarter | +116.70% |
BSE results filing, NSE: BRAWN. Figures extracted from the filing.
Brawn Biotech Ltd: key numbers
- Share price
- ₹25.50
- Market cap
- ₹7.65 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 8.9×Sector 47.4×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brawn Biotech Ltd
All →Brawn Biotech Other Announcement
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd has filed the notice for its 41st Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.
Brawn Biotech Board Meeting Date
Brawn Biotech Ltd has scheduled a Board Meeting for August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Brawn Biotech Other Announcement
Brawn Biotech Ltd notified BSE regarding the non-applicability of Regulation 24A for Annual Secretarial Compliance Report. The company remains below the mandatory reporting thresholds for capital and networth.
Brawn Biotech Q4 FY26 Results: Net Profit ₹0.6 Cr, Down 53.8% YoY
Brawn Biotech Ltd reported revenue from operations of ₹2 Cr (-65.5% YoY) and net profit of ₹0.6 Cr (-53.8% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.6 Cr · -53.8% YoY
Brawn Biotech Financial Results
Brawn Biotech Ltd reported standalone annual revenue of ₹17.43 Crore for FY26. The Board approved these audited financial results during its meeting on May 29, 2026.
- Value
- ₹17.43 Cr